GMAB - Pfizer Genmab cervical cancer therapy wins full FDA approval
2024-04-30 06:26:54 ET
Pfizer ( NYSE: PFE ) and Danish drugmaker Genmab ( GMAB ) announced Monday that the U.S. FDA accepted a supplemental Biologics License Application granting full approval for their cervical cancer therapy, Tivdak (tisotumab vedotin-tftv)....
Pfizer, Genmab cervical cancer therapy wins full FDA approval